                               SEQUENCE LISTING

<110> PRESIDENT AND FELLOWS OF HARVARD COLLEGE
 
<120> A METHOD OF AMPLIFYING SINGLE CELL TRANSCRIPTOME

<130> 010498.01108/WO

<140>
<141>

<150> 62/512,144
<151> 2017-05-29

<160> 7     

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
hbdvhbdvhb dvhbdvhbdv                                                   20


<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
vdbhvdbhvd bhvdbhvdbh                                                   20


<210> 3
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
gtaggtgtga gtgatggttg aggtagt                                           27


<210> 4
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
gtgagtgatg gttgaggtag tgtggag                                           27


<210> 5
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
agtcgcttgg gtgtagtgc                                                    19


<210> 6
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> misc_feature
<222> (1)..(30)
<223> This sequence may encompass 10-30 nucleotides

<400> 6
tttttttttt tttttttttt tttttttttt                                        30


<210> 7
<211> 12
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
tttttttttt tt                                                           12

